Creative Medical Technology Holdings, Inc.

Yield per half year: -34.17%
Dividend yield: 0%
Sector: Healthcare

Creative Medical Technology Holdings, Inc.

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
0/10
-0.8406 -205.4 -99.59% 0.0854 -1 084%
P/S 314.93 61.67 410.66%
P/BV 0.5463 245 -99.78%
P/FCF -0.871 -119.7 -99.27%
Ev/Ebitda 0.4396 12.25 -96.41%
Ev/S -225.11 489.61 -145.98%
Ev/FCF 0.4671 -249.08 -100.19%
E/P -1.19 0.0233 -5206.9%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
0/10
-51212.81 -380.31 13366.09% -45298.39 +13.06%
ROE -65.85 109.03 -160.39%
ROA -63.2 -2.42 2508.34%
ROIC 0 0.8343 -100%
ROS -49940.74 -305.78 16232.48%
ROCE -90.58 4.21 -2250.85%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
-0.0025 0.9664 -100.26% -0.0023 +9.3%
Nеt Debt/Ebitda 1.05 1.02 3.59%
Debt/Ratio 0.0021 0.1833 -98.84%
Debt/Equity 0.0517 1.65 -96.87%
Debt/Net Income -0.0026 -1.72 -99.85%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 0.544 -100% 0 0%
Number of years of dividend growth 0 0.8372 -100%
DSI 0 0.211 -100%
Average dividend growth 0 2.34 -100%
Average percentage for 5 years 0 0.5289 -100%
Average percentage for payments 0.0669 59.41 -99.89%
Difference from average difference in sector -0.544

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
0/10
-93.33 -99.59 -6.29%
Growth impulse Ebitda in 5 years 463.34 -151.38 -406.08%
Growth impulse Net Income in 5 years -92.19 -114.89 -19.76%
Growth impulse FCF in 5 years 1118.69 -159.77 -800.19%
Growth impulse EPS in 5 years -96.94 -106.16 -8.69%
IP Score
3.75/10

Similar companies

Alexion

Gilead Sciences

ABIOMED

Amgen

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription